[en] In vitro risk assessment of dietary contaminants has become a priority in human food safety. This paper proposes an in vitro approach associating different complementary tools in an original toolbox and aims to improve the assessment of the toxicological impact of dietary contaminants at realistic human exposure levels, with a special focus on the intestinal compartment. The system is based on the use of four complementary cellular tools, namely stress gene induction in transgenic strains of Escherichia coli, modulation of the activity of key biotransformation enzymes (cytochrome P-450 (CYP) 1A1 and 3A4) in a human intestinal cell line, and activation of aryl hydrocarbon receptor (AhR) and oestrogenic receptor (ER)-dependent genes in agonistic and antagonistic assays with luciferase reporter cells. It was applied to four chosen model molecules: ochratoxin A (OTA) and deoxynivalenol (DON), two common food-borne mycotoxins, and imazalil (IMA) and benomyl (BEN), two fungicides widely occurring in foodstuffs. All these assays were performed at or around a realistic intestinal concentration, determined through a deterministic approach based on the calculation of a theoretical maximum daily intake (TMDI). Using the four model molecules, it is clearly highlighted that induction of CYP1A1 activity and inhibition of CYP3A4 activity occurred in Caco-2 cells at a realistic intestinal concentration of IMA. Furthermore, some bacterial stress genes were induced in a range of realistic concentrations, following exposure to DON and IMA. In addition, BEN clearly provoked an ER agonistic activity in a human oestrogen sensitive reporter cell line. All these results are in accordance with the literature, suggesting that the in vitro toolbox constitutes an interesting approach in order to obtain a first 'fingerprint' of dietary contaminants at realistic human exposure for further risk assessment.
Aarts JMMJG, Haan LHJd, Schalk JAC, Cox MA, Brouwer A. 1993. Ah receptor-mediated luciferase expression: a tool for monitoring dioxin-like toxicity. Organohalogen Compound. 13:361.
Ashida H, Nishiumi S, Fukuda I. 2008. An update on the dietary ligands of the AhR. Expert Opin Drug Metab Toxicol. 4(11):1429-1447.
Banks D, Soliman MRI. 1997. Protective effects of antioxidants against benomyl-induced lipid peroxidation and glutathione depletion in rats. Toxicology. 116:177-181.
Berger V, Gabriel AF, Sergent T, Trouet A, Larondelle Y, Schneider YJ. 2003. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicol Lett. 140-141:465-476.
Bock KW, Kohle C. 2006. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol. 72(4):393-404.
Bony S, Carcelen M, Olivier L, Devaux A. 2006. Genotoxicity assessment of deoxynivalenol in the Caco-2 cell line model using the Comet assay. Toxicol Lett. 166 (1):67-76.
Boulenc X, Bourrie M, Fabre I, Roque C, Joyeux H, Berger Y, Fabre G. 1992. Regulation of cytochrome P4501A1 gene expression in a human intestinal cell line, Caco-2. J Pharmacol Exp Ther. 263(3):1471-1478.
Braniste V, Leveque M, Buisson-Brenac C, Bueno L, Fioramonti J, Houdeau E. 2009. Oestradiol decreases colonic permeability through oestrogen receptor-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells. J Physiol. 587 (13):3317-3328.
Buchthal J, Grund KE, Buchmann A, Schrenk D, Beaune P, Bock KW. 1995. Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucur-onosyltransferase in biopsies of human duodenal mucosa. Eur J Clin Pharmacol. 47(5):431-435.
Cani PD, Delzenne NM. 2009. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol. 9:737-743.
Cetin Y, Bullerman LB. 2005. Cytotoxicity of Fusarium mycotoxins to mammalian cell cultures as determined by the MTT bioassay. Food Chem Toxicol. 43 (5):755-764.
Claeys WL, de Voghel S, Schmita J-F, Vromman V, Pussemier L. 2008. Exposure assessment of the Belgian population to pesticide residues through fruit and vegetable consumption. Food Addit Contam A. 25 (7):851-863.
Creppy EE, Chiarappa P, Baudrimont I, Borracci P, Moukha S, Carratu MR. 2004. Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity? Toxicology. 201 (1-3):115-123.
Dardenne F, Dongen SV, Nobels I, Smolders R, Coen WD, Blust R. 2008. Mode of action clustering of chemicals and environmental samples on the bases of bacterial stress gene inductions. Toxicol Sci. 101(2):206-214.
Dardenne F, Nobels I, Coen WD, Blust R. 2007. Doseresponse relationships and statistical performance of a battery of bacterial gene profiling assays. Environ Biotech. 75:223-234.
Delescluse C, Lemaire G, de Sousa G, Rahmani R. 2000. Is CYP1A1 induction always related to AHR signaling pathway? Toxicology. 153:73-82.
Denison MS, Nagy SR. 2003. Activation of the aryl hydrocarbon receptor by structuraly diverse exogenous and endogenous chemicals. Ann Rev Pharmacol Toxicol. 43:309-334.
Denison MS, Whitlock Jr JP. 1995. Xenobiotic-inducible transcription of cytochrome P450 genes. J Biol Chem. 270 (31):18175-18178.
Dierickx PJ. 1999. CYP1/2 activation and glutathione-dependent cytotoxicity of four pesticides in Hep G2 and Fa32 cells. Toxicol In Vitro. 13(4-5):779-783.
Dougherty CP, Holtz SH, Reinert JC, Panyacosit L, Axelrad DA, Woodruff TJ. 2000. Dietary exposures to food contaminants across the United States. Environ Res. 84 (2):170-185.
European Commission. 2002. Assessment of dietary intake of Ochratoxin A by the population of EU Member states. Brussels (Belgium): European Commission, Health and Consumers Protection Directorate-General.
European Commission. 2003. Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU Member States. Brussels (Belgium): European Commission, Health and Consumers Protection Directorate-General.
European Food Safety Authority (EFSA). 2004. Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the commission related to ochratoxin A as undesirable substance in animal feed. EFSA J. 101:1-36.
European Food Safety Authority (EFSA). 2006. Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the commission related to ochratoxin A in food. EFSA J. 365:1-56.
European Food Safety Authority (EFSA). 2007. Opinion of the scientific panel on plant protection products and their residues on a request from the commission on the acute reference dose (ARfD) for imazalil. EFSA J. 460:1-15.
Fallone F, Villard P-H, Decome L, Seree E, Meo Md, Chacon C, Durand A, Barra Y, Lacarelle B. 2005. PPAR-activation potentiates AhR-induced CYP1A1 expression. Toxicology. 216(2-3):122-128.
Fallone F, Villard P-H, Seree E, Rimet O, Nguyen QB, Bourgarel-Rey V, Fouchier F, Barra Y, Durand A, Lacarelle B. 2004. Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressor. Biochem Biophys Res Comm. 322(2):551-556.
Fontana RJ, Lown KS, Paine MF, Fortlage L, Santella RM, Felton JS, Knize MG, Greenberg A, Watkins PB. 1999. Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology. 117(1):89-98.
Gallagher EP, Wienkers LC, Stapleton PL, Kunze KL, Eaton DL. 1994. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Cancer Res. 54(1):101-108.
Ghannoum MA, Rice LB. 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 12 (4):501-517.
Gibbs MA, Baillie MT, Shen DD, Kunze KL, Thummel KE. 2000. Persistent inhibition of CYP3A4 by ketoconazole in modified Caco-2 cells. Pharmaceut Res. 17(3):299-305.
Giroux V, Lemay F, Bernatchez G, Robitaille Y, Carrier JC. 2008. Estrogen receptor deficiency enhances small intestinal tumorigenesis in ApcMin/{thorn} mice. Int J Cancer. 123 (2):303-311.
Goodwin B, Redinbo M, Kliewer S. 2002. Regulation of CYP3A gene transcription by the pregnane X receptor. Ann Rev Pharmacol Toxicol. 42:1-23.
Grodstein F, Newcomb PA, Stampfer MJ. 1999. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med. 106 (5):574-582.
Guengerich FP. 1997. Role of cytochrome P450 enzymes in drug-drug interactions. Adv Pharmacol. 43:7-35.
Guengerich FP. 1999. Cytochrome P-450 3A4: regulation and role in drug metabolism. Ann Rev Pharmacol Toxicol. 39:1-17.
Guengerich FP, Shimada T. 1998. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 400 (1-2):201-213.
Hewitt MJ, Mutch P, Pratten MK. 2005. Potential teratogenic effects of benomyl in rat embryos cultured in vitro. Reproduct Toxicol. 20(2):271-280.
Hou X-L, Takahashi K, Kinoshita N, Qiu F, Tanaka K, Komatsu K, Takahashi K, Azuma J. 2007. Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1,25 dihydroxyvitamin D3 treated Caco-2 cells. Int J Pharmaceut. 337(1-2):169-177.
Igbedioh SO, Akinyele IO. 1992. Effect of benomyl toxicity on some constituents of albino rats. Arch Environ Hlth. 47 (4):314-317.
International Agency for Research on Cancer (IARC). 1993. Ochratoxin A. IARC Monogr Eval Carcinogen Risk Human. 56:489-521.
Kamp HG, Eisenbrand G, Schlatter J, Wurth K, Janzowski C. 2005. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology. 206(3):413-425.
Kawajiri K, Fujii-Kuriyama Y. 2007. Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor. Arch Biochem Biophys. Highlight Issue: Enzymology of Drug Metabolism and Toxicology. 464(2):207-212.
Kawano N, Koji T, Hishikawa Y, Murase K, Murata I, Kohno S. 2004. Identification and localization of estrogen receptor and -positive cells in adult male and female mouse intestine at various estrogen levels. Histochem Cell Biol. 121(5):399-405.
Kouadio JH, Dano SD, Moukha S, Mobio TA, Creppy EE. 2007. Effects of combinations of Fusarium mycotoxins on the inhibition of macromolecular synthesis, malondialdehyde levels, DNA methylation and fragmentation, and viability in Caco-2 cells. Toxicon. 49 (3):306-317.
Kouadio JH, Mobio TA, Baudrimont I, Moukha S, Dano SD, Creppy EE. 2005. Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology. 213:56-65.
Kroes R, Muller D, Lambe J, Lowik MR, van Klaveren J, Kleiner J, Massey R, Mayer S, Urieta I, Verger P, et al. 2002. Assessment of intake from the diet. Food Chem Toxicol. 40(2-3):327-385.
Lampen A, Bader A, Bestmann T, Winkler M, Witte L, Borlak JT. 1998. Catalytic activities, protein and mRNA- expression of cytochrome P450 isoenzymes in intestinal cell lines. Xenobiotica. 28(5):429-441.
Lampen A, Meyer S, Arnhold T, Nau H. 2000. Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes. J Pharmacol Exp Ther. 295 (3):979-985.
Laparra JM, Sanz Y. 2010. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res. 61:219-225.
le Maire A, Bourguet W, Balaguer P. 2010. A structural view of nuclear hormone receptor: endocrine disruptor interactions. Cell Mol Life Sci. 67(8):1219-1237.
Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. 2003. Characterization of the oxidative metabolites of 17-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology. 144 (8):3382-3398.
Lemaire G, Mnif W, Mauvais P, Balaguer P, Rahmani R. 2006a. Activation of - and -estrogen receptors by persistent pesticides in reporter cell lines. Life Sci. 79:1160-1169.
Lemaire G, Mnif W, Pascussi J-M, Pillon A, Rabenoelina F, Fenet Hln, Gomez E, Casellas C, Nicolas J-C, Cavailles V, et al. 2006b. Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. Toxicol Sci. 91(2):501-509.
Lindell M, Karlsson MO, Lennernas H, Pahlman L, Lang MA. 2003. Variable expression of CYP and Pgp genes in the human small intestine. Eur J Clin Investigat. 33 (6):493-499.
Looijer-van Langen M, Hotte N, Dieleman LA, Albert E, Mulder C, Madsen KL. 2011. Estrogen receptor signaling modulates epithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 300(4):G621-G626.
Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W, Watkins PB. 1997. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Investigat. 99(10):2545-2553.
Ma Q. 2001. Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor regulation, and expanding biological roles. Curr Drug Metab. 2:149-164.
Maaroufi K, Achour A, Betbeder AM, Hammami M, Ellouz F, Creppy EE, Bacha H. 1995. Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol. 69:552-558.
Maresca M, Mahfoud R, Garmy N, Fantini J. 2002. The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells. J Nutr. 132(9):2723-2731.
Marill J, Cresteil T, Lanotte M, Chabot GG. 2000. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol. 58(6):1341-1348.
McCarroll N, Protzel A, Joannou Y, Stack HF, Jackson MA, Waters MD, Dearfield KL. 2002. A survey of EPA/OPP and open literrature on selected pesticide chemicals III. Mutagenicity and carcinogenicity of benomyl and carbendazim. Mutat Res. 512:1-35.
McKinlay R, Plant JA, Bell JNB, Voulvoulis N. 2008. Calculating human exposure to endocrine disrupting pesticides via agricultural and non-agricultural exposure routes. Sci Total Environ. 398(1-3):1-12.
McSorley LC, Daly AK. 2000. Identification of human cytochrome P450 isoforms that contribute to all-transretinoic acid 4-hydroxylation. Biochem Pharmacol. 60 (4):517-526.
Meky FA, Turner PC, Ashcroft AE, Miller JD, Qiao YL, Roth MJ, Wild CP. 2003. Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol. 41(2):265-273.
Mimura J, Fujii-Kuriyama Y. 2003. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta Gen Subj. 1619(3):263-268.
Morinaga H, Yanase T, Nomura M, Okabe T, Goto K, Harada N, Nawata H. 2004. A benzimidazole fungicide, benomyl, and its metabolite, carbendazim, induce aroma-tase activity in a human ovarian granulose-like tumor cell line (KGN). Endocrinology. 145(4):1860-1869.
Murray M. 2006. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab. 7(1):67-81.
Muto N, Hirai H, Tanaka T, Itoh N, Tanaka K. 1997. Induction and inhibition of cytochrome P450 isoforms by imazalil, a food contaminant, in mouse small intestine and liver. Xenobiotica. 27(12):1215-1223.
Nakagawa Y, Moore GA. 1995. Cytotoxic effects of postharvest fungicides, ortho-phenylphenol, thiabendazole and imazalil, on isolated rat hepathocytes. Life Sci. 57 (15):1433-1440.
Nebert D, Dalton T, Okey A, Gonzalez F. 2004. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem. 279(23):23847-23850.
Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson J-A. 2001. Mechanisms of estrogen action. Physiol Rev. 81(4):1535-1565.
Ohtake F, Baba A, Fujii-Kuriyama Y, Kato S. 2008. Intrinsic AhR function underlies cross-talk of dioxins with sex hormone signalings. Biochem Biophys Res Comm. 370:541-546.
Ohtake F, Fujii-Kuriyama Y, Kato S. 2009. AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochem Pharmacol. 77:474-484.
Orser CS, Foong FCF, Capaldi SR, Nalezny J, Mackay W, Benjamin M. 1995. Use of prokaryotic stress promotors as indicators of the mechanisms of chemical toxicity. In Vitro Toxicol. 8:71-85.
Osborne C, Wakeling A, Nicholson R. 2004. Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer. 90:S2-S6.
Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC. 2006. The human intestinal cytochrome P450 'pie'. Drug Metab Disposit. 34(5):880-886.
Paine MF, Khalighi M, Fisher JM, Shen DD, Kunze KL, Marsh CL, Perkins JD, Thummel KE. 1997. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther. 283(3):1552-1562.
Paine MF, Schmiedlin-Ren P, Watkins PB. 1999. Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazole. Drug Metab Disposit. 27(3):360-364.
Parl FF, Dawling S, Roodi N, Crooke PS. 2009. Estrogen metabolism and breast cancer. Ann NY Acad Sci. 1155 (1):68-75.
Pestka JJ, Smolinski AT. 2005. Deoxynivalenol: toxicology and potential effects on humans. J Toxicol Environ Hlth B Crit Rev. 8(1):39-69.
Petzinger E, Ziegler K. 2000. Ochratoxin A from a toxicological perspective. J Vet Pharmacol Ther. 23 (2):91-98.
Pfohl-Leszkowicz A, Manderville RA. 2007. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res. 51:61-99.
Poulsen ME, Andersen JH. 2003. Results from the monitoring of pesticide residues in fruit and vegetables on the Danish market, 2000-01. Food Addit Contam A. 20 (8):742-757.
Prueksaritanont T, Gorham LM, Hochman JH, Tran LO, Vyas KP. 1996. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab Disposit. 24(6):634-642.
Quillardet P, Hofnung M. 1985. The SOS Chromotest, a colorimetric bacterial assay for genotoxins-procedures. Mutat Res. 147:65-78
Radic B, Fuchs R, Peraica M, Lucic A. 1997. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol Lett. 91(2):105-109.
Rey-Grobellet X, Ferre N, Eeckhoutte C, Larrieu G, Pineau T, Galtier P. 1996. Structural requirements for the induction of cytochromes P450 by benzimidazole anthelmintic derivatives in cultured rabbit hepatocytes. Biochem Biophys Res Comm. 220:789-794.
Ringot D, Chango A, Schneider Y-J, Larondelle Y. 2006. Toxicokinetics and toxicodynamics of ochratoxin A, un update. Chem-Biol Interact. 159:18-46.
Rosenberg DW, Leff T. 1993. Regulation of cytochrome P450 in cultured human colonic cells. Arch Biochem Biophys. 300(1):186-192.
Rotter BA, Prelusky DB, Pestka JJ. 1996. Toxicology of deoxynivalenol (vomitoxin). J Toxicol Environ Hlth. 48 (1):1-34.
Schmiedlin-Ren P, Thummel KE, Fisher JM, Paine MF, Lown KS, Watkins PB. 1997. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1,25-dihydroxyvitamin D3. Mol Pharmacol. 51 (5): 741-754.
Schwarz D, Kisselev P, Cascorbi I, Schunck WH, Roots I. 2001. Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis. 22(3):453-459.
Scientific Committee on Food (SCF). 1998. Opinion of the Scientific Committee on Food on ochratoxin A. Brussels (Belgium): European Commission, Health and Consumers Protection Directorate-General.
Scientific Committee on Food (SCF). 2002. Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group evaluation of T-2 toxin, HT-2 toxin, nivalenol and deoxynivalenol. Brussels (Belgium): European Commission, Health and Consumers Protection Directorate-General.
Scippo M-L, Argiris C, Weerdt CVD, Muller M, Willemsen P, Martial J, Maghuin-Rogister G. 2004. Recombinant human estrogen, androgen and progesterone receptors for detection of potential endocrine disruptors. Analyt Bioanalyt Chem. 378:664-669.
Seree E, Villard PH, Pascussi JM, Pineau T, Maurel P, Nguyen QB, Fallone F, Martin P-M, Champion S, Lacarelle B, et al. 2004. Evidence for a new human CYP1A1 regulation pathway involving PPAR- and 2 PPRE sites. Gastroenterology. 127(5):1436-1445.
Sergent T, Dupont I, Jassogne C, Ribonnet L, van der Heiden E, Scippo M-L, Muller M, McAlister D, Pussemier L, Larondelle Y, et al. 2009. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells - comparison with other conazole pesticides. Toxicol Lett. 184(3):159-168.
Sergent T, Parys M, Garsou S, Pussemier L, Schneider Y-J, Larondelle Y. 2006. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol Lett. 164(2):167-176.
Sergent T, Ribonnet L, Kolosova A, Garsou S, Schaut A, de Saeger S, van Peteghem C, Larondelle Y, Pussemier L, Schneider Y-J. 2008. Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food Chem Toxicol. 46(3):813-841.
Shimada T, Guengerich FP. 1989. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci USA. 86(2):462-465.
Shimada T, Oda Y, Gillam EM, Guengerich FP, Inoue K. 2001. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab Disposit. 29(9):1176-1182.
Singh S, Poulsom R, Hanby AM, Rogers LA, Wright NA, Sheppard MC, Langman MJS. 1998. Expression of oestrogen receptor and oestrogen-inducible genes pS2 and ERD5 in large bowel mucosa and cancer. J Pathol. 184 (2):153-160.
Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit AW. 2008. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharmaceut. 363:1-25.
Stoev SD. 1998. The role of ochratoxin A as a possible cause of Balkan endemic nephropathy and its risk evaluation. Vet Hum Toxicol. 40(6):352-360.
Studer-Rohr I, Schlatter J, Dietrich DR. 2000. Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol. 74 (9):499-510.
Takeuchi S, Iida M, Yabushita H, Matsuda T, Kojima H. 2008. In vitro screening for aryl hydrocarbon receptor agonistic activity in 200 pesticides using a highly sensitive reporter cell line, DR-EcoScreen cells, and in vivo mouse liver cytochrome P450-1 A induction by propanil, diuron and linuron. Chemosphere. 74:155-165.
Takeuchi S, Matsuda T, Kobayashi S, Takahashi T, Kojima H. 2006. In vitro screening of 200 pesticides for agonistic activity via mouse peroxisome proliferatoractivated receptor (PPAR) and PPAR and quantitative analysis of in vivo induction pathway. Toxicol Appl Pharmacol. 217:235-244.
Tsuchiya Y, Nakajima M, Yokoi T. 2005. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett. 227(2):115-124.
Uno S, Dalton TP, Derkenne S, Curran CP, Miller ML, Shertzer HG, Nebert DW. 2004. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol. 65(5):1225-1237.
Van de Walle J, Romier B, Larondelle Y, Schneider Y-J. 2008. Influence of deoxynivalenol on NF-B activation and IL-8 secretion in human intestinal Caco-2 cells. Toxicol Lett. 177(3):205-214.
van der Heiden E, Bechoux N, Muller M, Sergent T, Schneider Y-J, Larondelle Y, Maghuin-Rogister G, Scippo M-L. 2009. Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays. Analyt Chim Acta. 637:337-345.
Vanden Bossche H, Engelen M, Rochette F. 2003. Antifungal agents of use in animal health - chemical, biochemical and pharmacological aspects. J Vet Pharmacol Ther. 26:5-29.
Verger P. 2006. Methodes classiques d'evaluation du risque. Analyse des risques alimentaires. ETDOC. Lassay-lesChateaux. Lavoisier:125-141.
Vinggaard AM, Hnida C, Breinholt V, Larsen JC. 2000. Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicol In Vitro. 14:227-234.
Vrabcheva T, Usleber E, Dietrich R, Martlbauer E. 2000. Co-occurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J Agricult Food Chem. 48(6):2483-2488.
Willemsen P, Scippo M-L, Kausel G, Figueroa J, Maghuin-Rogister G, Martial JA, Muller M. 2004. Use of reporter cell lines for detection of endocrine-disrupter activity. Analyt Bioanalyt Chem. 378:655-663.
World Health Organization (WHO). 1997. Guidelines for predicting dietary intake of pesticide residues (revised). Geneva (Switzerland): WHO.
World Health Organization (WHO). 2001. Evaluation of certain mycotoxins in food: fifty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. Geneva (Switzerland): WHO.
World Health Organization (WHO). 2003. GEMS/Food regional diets. Geneva (Switzerland): WHO, Food Safety Department.
Zhang QY, Dunbar D, Ostrowska A, Zeisloft S, Yang J, Kaminsky LS. 1999. Characterization of human small intestinal cytochromes P-450. Drug Metab Disposit. 27 (7):804-809.
Zhou HR, Lau AS, Pestka JJ. 2003. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenolinduced ribotoxic stress response. Toxicol Sci. 74 (2):335-344.
